Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Therapeutics and Clinical Risk Management, 09/29/09
Ricciardi S et al. – Pemetrexed is a new cytotoxic agent that is a standard of care for the second–line treatment of non–small cell lung cancer (NSCLC) and in combination with cisplatin in treatment of malignat pleural mesothelioma. It has been studied in numerous phase II and III trials in combination with different drugs or as single agent. Recently, pemetrexed has been approved in combination with cisplatin for the first–line treatment of patients with locally advanced or metastatic NSCLC other than squamous cell histology. The toxicity is acceptable and similar to that of other NSCLC regimens. The postinduction maintenance therapy with pemetrexed is being evaluated in a phase III, double–blind, placebo–controlled study.
Related Articles
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09
Relevance Score: 69%
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09
Relevance Score: 69%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09
Relevance Score: 68%
Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Today in Pulmonology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
All Men Are Created Equal? New Leads in Explaining Sex Differences in Adult Asthma
Proceedings of the American Thoracic Society, 12/18/09
Systemic and Local Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the American Thoracic Society, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor